Graig Suvannavejh

Stock Analyst at Mizuho

(0.78)
# 2344
Out of 5,382 analysts
180
Total ratings
Success rate
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
IMRX Immuneering
Maintains: Outperform
8 10
3.04 228.95% 2 Jun 18, 2025
INSM Insmed
Maintains: Outperform
96 110
104.86 4.9% 7 Jun 11, 2025
CRVS Corvus Pharma
Maintains: Outperform
12 11
4.09 168.95% 2 May 20, 2025
EYPT EyePoint Pharmaceuti...
Maintains: Outperform
30 26
10.55 146.45% 5 May 16, 2025
HRMY Harmony Biosciences ...
Maintains: Outperform
44 48
31.6 51.9% 18 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
30 20
18.39 8.75% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
7 8
6.25 28% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
38 33
31.95 3.29% 8 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
212 216
103.54 108.62% 21 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
140 132
n/a n/a 11 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
3 2
n/a n/a 2 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 8
2.31 229% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
8.64 756.48% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5 1
n/a n/a 3 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
44 49
52.27 -6.26% 6 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
22.02 127.07% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
0.81 2369.14% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 16
5.47 192.5% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 22
2.54 766.14% 4 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25 45
n/a n/a 9 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 10
4.07 145.7% 5 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 9
1.5 500% 4 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
64
2.04 3037.25% 8 Aug 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
274 258
n/a n/a 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 1
2.9 -65.52% 5 Jun 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
7.94 88.92% 1 Mar 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 35
62.35 -43.87% 5 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 8
3.69 116.8% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
71 57
33.14 72% 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
8 5
37.25 -86.58% 4 Apr 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
n/a n/a 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 6
n/a n/a 2 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
53
n/a n/a 1 Jul 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
5.73 493.37% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
28
3.98 603.52% 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
14.38 115.58% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
19
0.22 8536.36% 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
5
1.78 166.85% 1 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
36
14.45 149.13% 2 Nov 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 1 Oct 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
37
0.86 4202.33% 1 Oct 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
128
107.12 19.49% 1 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 10
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
29
n/a n/a 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
35
n/a n/a 1 Jan 8, 2020